If you’re looking for MS care in Maryland, you’ll find options across major academic centers and regional clinics from Baltimore to surrounding areas. Use this guide to compare approaches at places like Johns Hopkins, the University of Maryland, Sinai Neurology Associates, and other local centers so you can choose the team and setting that fit your needs.
5 MS treatment centers in Maryland24 active clinical trialsTop academic centers: Johns Hopkins, University of Maryland18 providers with Medicare prescribing data
Center types in Maryland
Regional Neurology Group (3)
Academic MS Center (2)
Filter by type:
60% of MS centers in Maryland are classified as Regional Neurology Group facilities.
Centers with Most Active Trials in Maryland
Ranked by active clinical trial count from ClinicalTrials.gov. Not a quality ranking.
Largest Care Teams in Maryland
1. Johns Hopkins Multiple Sclerosis Center9 providers
MS Care by City
Active MS clinical trials in Maryland
See all 37 MS trials in Maryland →ActivePhase 3
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
Hoffmann-La Roche
Lutherville
ActivePhase 4
A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation
Novartis Pharmaceuticals
Lutherville
ActivePhase 3
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
Frederick
ActivePhase 3
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
Baltimore
ActivePhase 3
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Novartis Pharmaceuticals
Bethesda · Lutherville
ActivePhase 3
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
Bethesda
ActivePhase 3
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
Hoffmann-La Roche
Baltimore


